How to Get Published in Nature: What Editors Actually Look For

Getting published in Nature is a goal for researchers across every scientific discipline. Nature (IF 48.5) is the most broadly read scientific journal in the world, and a publication there signals that a finding matters beyond a single field. The competition is intense, the standards are unambiguous, and most manuscripts fail before external peer review begins.

This guide covers what Nature's editors actually look for, what causes desk rejection, and how to prepare a manuscript that gives you a real shot at external review.

What Nature Actually Publishes

Nature's own description of its scope is useful: it publishes research of exceptional importance that advances scientific knowledge and has broad appeal. The key phrase is "broad appeal." A paper that makes a fundamental contribution to structural biology but is only of interest to structural biologists won't make it at Nature - it belongs in a specialty journal. A paper that reveals a universal principle about how cells respond to stress, written in a way that immunologists, neuroscientists, and cancer biologists can all learn from, is exactly what Nature wants.

The findings that succeed at Nature tend to share a few characteristics. They establish something genuinely new - not a refinement of an existing model but a challenge to it, an extension into new territory, or a discovery of something previously unknown. They use methods that are state-of-the-art for the question being asked. And they're written to be understood by scientists across disciplines, not just specialists in the subfield.

What doesn't make it: technically excellent incremental work, confirmatory studies that strengthen existing models without overturning them, findings of primary interest to a single specialist community, and work where the main advance is methodological rather than conceptual.

Understanding Nature's Desk Rejection Rate

Nature editors reject approximately 60% of manuscripts at the desk, a figure the journal's editors have stated publicly. Nature receives over 20,000 submissions per year and publishes under 7% of them. That means the majority of authors who submit to Nature never receive reviewer feedback - they receive an editorial rejection within one to two weeks.

Desk rejections happen when a handling editor determines that a manuscript doesn't meet Nature's threshold for broad significance or genuine novelty. Editors are generalist scientists with broad scientific reading. They're asking: is this finding new, does it matter beyond this subfield, and would a Nature reader who isn't a specialist in this area care about this result?

The most common desk rejection scenarios:

• A finding that's novel within a subfield but doesn't represent a conceptual advance that reaches beyond it
• A mechanism established in a model system without evidence that it applies broadly
• A claim of first-in-field that doesn't hold up against the recent literature
• Incremental contributions to an established body of work, regardless of sample size or technical sophistication

Avoiding desk rejection starts with being honest about whether your finding genuinely meets the broad-significance bar. If it requires significant specialist knowledge to understand why it matters, it probably doesn't.

The Novelty Bar: What It Actually Means

Novelty at Nature doesn't mean "this hasn't been shown before." It means "this changes how we think about something fundamental." There's a meaningful difference between those two things.

A paper that identifies a new gene involved in a known pathway is novel in the narrow sense - the gene wasn't previously identified. But it doesn't change the conceptual framework for understanding the pathway. A paper that shows a mechanism everyone assumed was cell-autonomous is actually systemic - that changes how the whole field thinks about the problem. That's Nature-level novelty.

Before submitting to Nature, ask: if this paper were published tomorrow, would researchers in three other fields care about it? Would it change how a neuroscientist, a cancer biologist, and a microbiologist think about their work? If the honest answer is only one of those three, it's probably a specialty journal paper regardless of technical quality.

What Your Figures Need to Show

Nature reviewers pay close attention to figures. The standard expectation is that the main figures tell a complete, compelling story in sequence - from the observation that motivated the study, through the mechanism, to the functional significance, with each panel building logically on the last.

A few specific things that come up in Nature reviews:

Model system validation is increasingly expected. Findings in a single model system - one cell line, one mouse strain, one organism - face questions about generalizability. Papers that validate a mechanism across two or three systems, or that include human tissue validation alongside animal model data, are substantially stronger.

Quantitative rigor is assumed. Statistical approaches need to be appropriate for the experimental design. N values need to be stated clearly. Error bars need to be defined. Multiple independent experiments or biological replicates are expected, not pooled technical replicates.

The final figure should close the loop. It should show the functional relevance of the mechanism established in earlier figures. A paper that identifies a mechanism without demonstrating that the mechanism matters functionally - that its disruption has a measurable consequence - leaves a gap that reviewers will flag.

The Cover Letter That Matters

At Nature, the cover letter is read. It's typically the first thing the handling editor sees before opening the manuscript. A cover letter that's a one-paragraph abstract summary wastes the opportunity.

An effective Nature cover letter does three things:

First, it establishes the fundamental problem and why it's unresolved. Not the entire field's history - two sentences that frame the gap. Second, it describes the central finding and makes the case for why it's a major advance, not an incremental one. This is where you argue broad significance. "Our finding that X challenges the longstanding assumption that Y" is the kind of statement that catches attention. Third, it explains the cross-disciplinary appeal. Why does this matter to scientists beyond your immediate specialty?

Keep it to three paragraphs. Editors read dozens of cover letters a day. A concise letter that makes the significance clear in 300 words is more effective than a thorough one that takes 600 words to get there.

Before You Submit: What Pre-Submission Review Catches

The biggest investment you can make before submitting to Nature is having a scientist who has published in this tier read your manuscript and tell you what they'd say as a reviewer.

The gaps that cause desk rejection and first-round rejection at Nature are specific and often invisible to authors who are too close to the work. Novelty claims that don't hold up against papers published in the last 12 months - papers the authors missed or underweighted. Model system limitations that need to be explicitly addressed. Missing rescue experiments that a reviewer at this level will immediately ask for. Conclusions that slightly overstep what the data can actually support.

Pre-submission review by a scientist with recent publications in Nature or equivalent journals surfaces these issues before they result in a rejection letter. You can learn about our desk rejection prevention service and what a pre-submission review covers in practice.

If you want a quick structural and scientific assessment before committing to a full expert review, the AI Diagnostic returns a structured report in 30 minutes and identifies the main gaps in your manuscript's scientific framing. For help deciding between Nature and its peers, see our Nature vs Science vs Cell comparison.

After Rejection: What to Do

Rejection from Nature is the most common outcome for even excellent manuscripts. What matters is what you do with it.

If the rejection is a desk rejection without comments, the manuscript likely needs either a repositioning argument or a different journal target. If the findings are genuinely strong but weren't framed for broad significance, the cover letter and introduction need to be rewritten before resubmitting to any top-tier journal.

If the rejection comes with editor or reviewer comments, read them carefully for what specific bar wasn't cleared. Then decide: can the bar be cleared with the existing data, or would it require new experiments? If new experiments are feasible and would genuinely elevate the manuscript, doing them before the next submission is usually the right call.

Our guide on manuscript revision after rejection covers how to approach that process systematically, and our guide on responding to reviewer comments is relevant if the rejection comes with substantive scientific feedback.

What teams underestimate in Nature editorial fit and execution

Most groups don't lose time because the science is weak. They lose time because the submission sequence is sloppy. A manuscript goes out with one unresolved weakness, gets predictable reviewer pushback, then the team spends 8 to 16 weeks fixing something that could have been caught before first submission. That's why a good pre-submission pass pays for itself even when the paper is already strong. You aren't buying generic feedback. You're buying a faster path to a decision that can actually move your project forward.

A practical pre-submission workflow that cuts revision cycles

Use a three-pass process. Pass one is claim integrity. For each major claim, ask what figure carries it and what competing explanation still survives. Pass two is reviewer simulation. Force one person on your team to argue from a skeptical reviewer position and write five hard comments before submission. Pass three is journal-fit edit. Tighten title, abstract, and first two introduction paragraphs so the paper reads like it belongs to that exact journal, not just any journal in the field. Teams that do this often reduce first-round revision scope by one-third to one-half.

Where strong manuscripts still get rejected

A lot of rejections come from mismatch, not low quality. The data may be strong, but the manuscript promises more than it suggests. Or the discussion claims broad relevance while the experiments only establish a narrow result. Another common issue is sequence logic. Figure 4 may be decisive, but it's buried after two weaker figures, so reviewers form a negative opinion before they reach the strongest evidence. Reordering figures and tightening claim language sounds minor, but it changes reviewer confidence quickly.

Example timeline from submission to decision

Here's a realistic timeline from teams we see often. Week 0: internal final draft. Week 1: external pre-submission review with field specialist comments. Week 2: targeted edits to claims, methods clarity, and figure order. Week 3: submit. Week 4 to 6: editor decision or external review invitation. Week 8 to 12: first decision. Compare that with the no-review path, where first submission leads to avoidable rejection and the same manuscript isn't resubmitted for another 10 to 14 weeks. The science hasn't changed, but total cycle time has.

Trade-offs you should decide before paying for review

Not every manuscript needs the same depth of feedback. If your team has two senior PIs with recent publications in the same journal tier, a focused external review may be enough. If this is a first senior-author paper, or the target journal is above your group's recent publication history, you need deeper critique on novelty framing and expected reviewer asks. Also decide whether speed or certainty matters more. A 48-hour light pass can catch clarity issues. A 5 to 7 day field-expert review is better for scientific risk.

Best for

• Authors deciding between these two venues for an active manuscript this month
• Labs that need a practical trade-off across fit, timeline, cost, and editorial bar
• Early-career researchers who need a realistic first-choice and backup choice

Not best for

• Choosing a journal from impact factor alone without checking scope fit
• Submitting before methods, controls, and framing match recent accepted papers
• Treating this comparison as a supports of acceptance at either journal

Sources

• Nature journal information and aims: nature.com/nature
• Clarivate Journal Citation Reports 2024 - Nature JIF: 48.5
• Nature editorial criteria: nature.com editorial criteria